Abstract:Objective: To elucidate the potential causality of leukocyte telomere length (LTL) with immune-mediated inflammatory diseases (IMIDs), we conducted a Mendelian randomization (MR) study. Methods: The genetically predicted causation between LTL and IMIDs was evaluated using a two-sample MR method. We analyzed 16 major IMIDs, which included systemic lupus erythematosus (SLE), inflammatory bowel disease (IBD), ulcerative colitis (UC), Crohn's disease (CD), ankylosing spondylitis (AS), sicca syndrome (SS), rheumatoid arthritis (RA), type 1 diabetes (T1D), primary sclerosing cholangitis (PSC), idiopathic pulmonary fibrosis (IPF), atopic dermatitis (AD), sarcoidosis, hypothyroidism, hyperthyroidism, psoriasis, and childhood asthma. The random-effects inverse-variance weighted (IVW) method was performed as the main analytical approach in MR. Various sensitivity analyses, including MR-Egger, MR robust adjusted profile score (MR-RAPS), weighted median, MR pleiotropy residual sum and outlier (MR-PRESSO) methods, weighted mode, radial plot, and radial regression, were used to guarantee the robustness of the results and detect horizontal pleiotropy. Cochran's Q value was calculated to check for heterogeneity, and the MR Steiger approach was used to test the causal direction. Results: The MR results indicated significant inverse associations of LTL with risks of psoriasis (OR: 0.77, 95% CI: 0.66–0.89, and p = 3.66 × 10 −4 ), SS (OR: 0.75, CI: 0.58–0.98, and p = 0.03), RA (OR: 0.77, 95% CI: 0.68–0.88, and p = 9.85 × 10 −5 ), hypothyroidism (OR: 0.84, 95% CI: 0.78–0.91, and p = 7,08 × 10 −6 ), hyperthyroidism (OR: 0.60, 95% CI: 0.44–0.83, and p = 1.90 × 10 −3 ), sarcoidosis (OR: 0.67, 95% CI: 0.54–0.83, and p = 2.60 × 10 −4 ), and IPF (OR: 0.41, 95% CI: 0.29–0.58, and p = 4.11 × 10 −7 ) in the FinnGen study. We observed that longer LTL was associated with an increased risk of AS susceptibility (OR: 1.51, 95% CI: 1.18–1.94, and p = 9.66 × 10 −4 ). The results of the IVW method showed no causal relationship between TL and SLE (OR: 0.92, 95% CI: 0.62–1.38, and p = 0.69) in the FinnGen study; however, a significantly positive correlation was shown between LTL and SLE in another larger GWAS (OR: 1.87, 95% CI: 1.37–2.54, and p = 8.01 × 10 −5 ). Conclusion: Our findings reveal that abnormal LTL has the potential to increase the risk of IMIDs. Therefore, it could be treated as a predictor and may provide new potential treatment targets for IMIDs. However, the change of LTL may not be the direct cause of IMIDs. Further studies should aim at the pathogenic mechanism or potential protective effects of LTL in IMIDs.

Shorter telomere length increases the risk of lymphocyte immunodeficiency: A Mendelian randomization study

The causal effect of telomere length on the risk of malignant lymphoma: A Mendelian randomization study

Causality between Telomere Length and the Risk of Hematologic Malignancies: A Bidirectional Mendelian Randomization Study

Immune-mediated inflammatory diseases and leukocyte telomere length: A Mendelian randomization study

Associations of genetically predicted circulating levels of cytokines with telomere length: a Mendelian randomization study

Telomere dysfunction: a potential cancer predisposition factor.

Genetically predicted telomere length and the risk of 11 hematological diseases: a Mendelian randomization study

Telomere length and aging-related outcomes in humans: A Mendelian randomization study in 261,000 older participants

Telomere Length and COVID-19 Outcomes: A Two-Sample Bidirectional Mendelian Randomization Study

A causal relationship between leukocyte telomere length and multiple sclerosis: A Mendelian randomization study

Genetically Predicted Longer Telomere Length is Associated with Increased Risk of B-cell Lymphoma Subtypes.

The Association of Telomere Length and Cancer: a Meta-analysis

Telomere length and development of systemic lupus erythematosus: a Mendelian randomization study

Telomere Dysfunction in Peripheral Lymphocytes As a Potential Predisposition Factor for Renal Cancer

Leukocyte Telomere Length and Bladder Cancer Risk: A Large Case-Control Study and Mendelian Randomization Analysis.

Telomere length and its association with systemic lupus erythematosus in an Asian population: A Mendelian randomization study

Association between genetically determined telomere length and health-related outcomes: A systematic review and meta-analysis of Mendelian randomization studies

Causal relationship between immune cells and telomere length: mendelian randomization analysis

Association between COVID‐19 and telomere length: a bidirectional Mendelian randomization study